Untitled

Kulikov, V. I.; Muzya, G. I.

doi:10.1023/a:1016146305000

Cited by 3 publications

(1 citation statement)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The cumulative effect of multicomponent rare-earth alloys has been pointed out in a significant number of papers on these issues [5]. The data on using rare-earth alloys of the ceric group [6] and the yttric group [7], as well as misch metal [8] have been cited. Tabular data frequently present just the total amounts of rare earth elements, i.e.…”

Section: Introductionmentioning

confidence: 99%

Thermodynamic Modeling of Phase Equilibrium in Fe-Y-Cr-C-O Liquid Metal System

Михайлов

Makrovets

2017

SSP

View full text Add to dashboard Cite

The thermodynamic characteristics of processes in the liquid metal system Fe–Y–Cr–C–O are considered as applied to low-carbon and low-alloy metal. The critical parameters for the state diagram of the oxide system Y2O3–Cr2O3 were established based on the values quoted in literature. The temperature dependence of the melting reaction constant Y2O3·Cr2O3 was determined. The coordinates of eutectic transformation points for the system Y2O3–Cr2O3 were calculated. In accordance with subregular solution theory, the energetic parameters which are necessary to calculate the activities Cr2O3 and Y2O3 of oxide melts in the system Y2O3–Cr2O3 were determined. The energetic parameters of subregular solution theories for the oxide system FeO–Cr2O3–Y2O3 were determined based on the values for the binary systems FeO–Y2O3, FeO–Cr2O3 and Y2O3–Cr2O3. The view of this diagram, as coupled with the existence domain of liquid metal within the framework of the quaternary system Fe–Y–Cr–O–С, suggests that low-carbon chromic liquid metal when injected with yttrium can form the following non-metallic inclusions: |Cr2O3|, |Y2O3|, |FeO·Cr2O3|, |Y2O3·Cr2O3| or oxide melt (FeO, Y2O3, Cr2O3). Oxide melt may contain up to 2 % of divalent chrome (Cr2+). The equilibrium constants for the main reactions of steel deoxidation with the formation of liquid, solid and gas products of chemical reactions were also established. The activity of components dissolved in metal was calculated using interaction parameters. The set of derived expressions for the activity of components and the dependences of equilibrium constants of chemical reactions and phase transformations allowed us to diagram the surface of component solubility in liquid metal (SCSM). SCSM diagrams show the compositions of liquid metal and indicate oxide phases which are in equilibrium with liquid metal.

show abstract

Section: Introductionmentioning

confidence: 99%

Thermodynamic Modeling of Phase Equilibrium in Fe-Y-Cr-C-O Liquid Metal System

Михайлов

Makrovets

2017

SSP

View full text Add to dashboard Cite

show abstract

Untitled

Kulikov¹,

Muzya²

2002

Biochemistry (Moscow)

View full text Add to dashboard Cite

The effects of platelet activating factor (PAF) and its cell analogs 1-O-alk-1;-enyl-2-acetyl-sn-glycero-3-phosphocholine (1-alkenyl-PAF) and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine (1-acyl-PAF) on chemotaxis of human leukocytes in vitro and their inflammatory and antiinflammatory activities in vivo were studied. Both analogs stimulated chemotaxis of human leukocytes in agarose gel. PAF and 1-alkenyl-PAF induced rat paw edema in the range of doses 0.1-10 and 10-100 micro g per paw, respectively. Paw edema induced by 1-acyl-PAF (10-100 micro g per paw) was more pronounced than that induced by PAF or 1-alkenyl-PAF. The latter also exhibited significant antiinflammatory effect by inhibiting PAF- or carrageenan-induced rat paw edema, and this effect exceeded that of dexamethasone. In these models of inflammation 1-acyl-PAF did not exhibit any antiinflammatory activity. The data suggest that PAF is not the only cell phospholipid mediating inflammation--its cell analogs, 1-acyl-PAF and 1-alkenyl-PAF, may also be involved into the inflammatory response. Possible interrelationships between cellular synthesis of 1-acyl-PAF, its formation in oxidized LDL, biological effects of lysolecithin, and penetration of LDL into the arterial wall are discussed.

show abstract

Recurrent Headache as the Main Symptom of Acquired Cerebral Toxoplasmosis in Nonhuman Immunodeficiency Virus-infected Subjects With no Lymphadenopathy

Prandota

2007

American Journal of Therapeutics

View full text Add to dashboard Cite

Headache and/or migraine, a common problem in pediatrics and internal medicine, affect about 5% to 10% children and adolescents, and nearly 30% of middle-aged women. Headache is also one of the most common clinical manifestations of acquired Toxoplasma gondii infection of the central nervous system (CNS) in immunosuppressed subjects. We present 11 apparently nonhuman immunodeficiency virus-infected children aged 7 to 17 years (8 girls, 3 boys) and 1 adult woman with recurrent severe headaches in whom latent chronic CNS T. gondii infection not manifested by enlarged peripheral lymph nodes typical for toxoplasmosis, was found. In 7 patients, the mean serum IgG Toxoplasma antibodies concentration was 189 +/- 85 (SD) IU/mL (range 89 to 300 IU/mL), and in 5 other subjects, the indirect fluorescent antibody test titer ranged from 1:40 to 1:5120 IU/mL (n= <1:10 IU/mL). Some of the patients suffered also from atopic dermatitis (AD) and were exposed to cat and/or other pet allergens, associated with an increased IL-4 and decreased IFN-gamma production. These cytokine irregularities caused limited control of cerebral toxoplasmosis probably because IL-4 down-regulated both the production of IFN-gamma and its activity, and stimulated production of a low NO-producing population of monocytes, which allowed cysts rupture, increased parasite multiplication and finally reactivation of T. gondii infection. The immune studies performed in 4 subjects showed a decreased percentage of T lymphocytes, increased total number of lymphocytes B and serum IgM concentration, and impaired phagocytosis. In addition, few of them had also urinary tract diseases known to produce IL-6 that can mediate immunosuppressive functions, involving induction of the anti-inflammatory cytokine IL-10. These disturbances probably resulted from the host protective immune reactions associated with the chronic latent CNS T. gondii infection/inflammation. This is consistent with significantly lower enzyme indoleamine 2,3-dioxygenase (IDO) activity reported in atopic than in nonatopic individuals, and an important role that IDO and tryptophan degradation pathways plays in both, the host resistance to T. gondii infection and its reactivation. Analysis of literature information on the subjects with different types of headaches caused by foods, medications, and other substances, may suggest that their clinical symptoms and changes in laboratory data result at least in part from interference of these factors with dietary tryptophan biotransformation pathways. Several of these agents caused headache attacks through enhancing NO production via the conversion of arginine to citrulline and NO by the inducible nitric oxide synthase enzyme, which results in the high-output pathway of NO synthesis. This increased production of NO is, however, quickly down-regulated by NO itself because this biomolecule can directly inactivate NOS, may inhibit Ia expression on IFN-gamma-activated macrophages, which would limit antigen-presenting capability, and block T-cell proliferation, thus ...

show abstract

Untitled

Cited by 3 publications

References 19 publications

Thermodynamic Modeling of Phase Equilibrium in Fe-Y-Cr-C-O Liquid Metal System

Thermodynamic Modeling of Phase Equilibrium in Fe-Y-Cr-C-O Liquid Metal System

Untitled

Recurrent Headache as the Main Symptom of Acquired Cerebral Toxoplasmosis in Nonhuman Immunodeficiency Virus-infected Subjects With no Lymphadenopathy

Contact Info

Product

Resources

About